HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,7-bis(2-hydroxyethyl)icaritin

inhibits phosphodiesterase-5A1 (PDE5A1); structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3,7-bis(2-hydroxyethyl)icaritin: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        3,7-bis(2-hydroxyethyl)icaritin: 1

Experts

1.	Chen, Xiao-Ling: 1 article (06/2018)
2.	Lan, Tao-Hua: 1 article (06/2018)
3.	Li, Jun-Zhe: 1 article (06/2018)
4.	Lin, Dong-Qun: 1 article (06/2018)
5.	Qiu, Hui-Liang: 1 article (06/2018)
6.	Ruan, Xin-Min: 1 article (06/2018)
7.	Wu, Yun-Shan: 1 article (06/2018)
8.	Xu, Dan-Ping: 1 article (06/2018)

Related Diseases

1.	Pulmonary Arterial Hypertension 06/15/2018 - "3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats."

Related Drugs and Biologics

1.	Type 5 Cyclic Nucleotide Phosphodiesterases
2.	Monocrotaline